Clinical Trial Update: Radiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck Cancer [NA]

View source ↗

Summary

A clinical trial evaluating radiation therapy with cetuximab for recurrent head and neck cancer was terminated, with results posted in March 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Head and Neck Cancer | NA | Status: TERMINATED | Results posted: 2014-03-12